Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
Turid Aas(Haukeland University Hospital), Anne‐Lise Børresen(Norwegian Cancer Society), Stephanie Geisler(Haukeland University Hospital), Birgitte Smith‐Sørensen(Norwegian Cancer Society), Hilde Johnsen(Norwegian Cancer Society), Jan Erik Varhaug(Haukeland University Hospital), Lars A. Akslen(Haukeland University Hospital), Per Eystein Lønning(Haukeland University Hospital)
Cited by 742
Abstract
Related Papers
No related papers found
Powered by citation graph analysis